<DOC>
	<DOCNO>NCT00830245</DOCNO>
	<brief_summary>To assess efficacy safety erlotinib non-small cell lung cancer patient leptomeningeal carcinomatosis</brief_summary>
	<brief_title>A Study Assess Efficacy Erlotinib Leptomeningeal Carcinomatosis EGFR Mutation Positive Non-small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Meningeal Carcinomatosis</mesh_term>
	<mesh_term>Erlotinib Hydrochloride</mesh_term>
	<criteria>1 . Age &gt; 18 2 . Histologically pathologically proven nonsmall cell lung cancer ( NSCLC ) 3 . Leptomeningeal carcinomatosis confirm CSF cytology 4 . A patient EGFR mutation ( include exon 19 deletion , L858R ) 5 . ECOG performance status 03 6 . Expected life time least 4 week 7 . A patient sign informed consent prior participation study 8 . Chemotherapynaïve patient eligible 9 . Previous EGFR TKI allow drug specifically use CNS metastases 1 . A pregnant lactating patient 2 . A patient childbearing potential without tested pregnancy baseline positive test . ( A postmenopausal woman amenorrhea period least 12 month longer consider nonchildbearing potential . ) 3 . A man woman childbearing potential without willingness use contraceptive measure study 4 . A patient history another malignant disease within past 3 year , except curatively treat basal cell carcinoma skin , cervical carcinoma situ , early gastric cancer 5 . A patient active interstitial lung disease , except simple lymphangitic lung metastasis 6 . A patient history allergic reaction gefitinib erlotinib 7 . The following laboratory test result : Number absolute neutrophils count ( ANC ) &lt; 1.0ⅹ109/L Number platelet &lt; 50 ⅹ109/L AST , ALT &gt; 2.5 ⅹupper limit normal Total bilirubin &gt; 1.5 ⅹupper limit normal Serum creatinine &gt; 1.5 ⅹupper limit normal 8 . A patient serious disease following Uncontrolled cardiac arrhythmia History myocardial infarction within 6 month prior initiation study Neurological psychiatric disorder include dementia uncontrolled seizure 9 . A patient refuse sign inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>EGFR mutation</keyword>
	<keyword>Erlotinib</keyword>
	<keyword>Lung cancer</keyword>
	<keyword>leptomeningeal carcinomatosis EGFR mutation positive non-small cell lung cancer</keyword>
</DOC>